Skip to content
Clinical Research Society

Clinical Research Society

International Society for Clinical Research and Translational Medicine

  • About Us
    • Executive Council
    • Committees
    • President’s Message
    • Code of Ethics
    • Our Logo
  • Membership
    • Professional Membership
    • Associate Membership
    • Student Membership
    • Institutional Membership
    • Membership Renewal
  • Training & Certification
    • GCP Certification
    • CRA Certification
    • CRC Certification
    • Emerging Clinical Research Professional
    • Project Management Certification
    • Training Demo
    • Register for Certification Exam
  • Careers
  • Contact

amylin

Clinical Research and Pharma News 

FDA approval for Lilly’s Bydureon delayed until Jan 28

0 Comments alkermes, amylin, bidureon, exanatide, lilly

Subsequent to a delay of one year for the approval of once-per-week diabetes drug Bydureon, the United States Food and

Read more
Clinical Research and Pharma News 

Amylin, Takeda discontinue development of obesity treatment

0 Comments amylin, metreleptin, pramlintide, takeda

Earlier on Thursday, Takeda Pharmaceutical Co. Ltd and Amylin Pharmaceuticals Inc. announced the discontinuation of the development of their combination

Read more
Clinical Research and Pharma News 

As Expenses Plummet, Amylin Pharma Narrows 2Q Losses

0 Comments amylin, bydureon, byetta

Earlier on Tuesday, Amylin Pharmaceuticals Inc. announced the narrowing of its losses in the second-quarter as the decline in costs

Read more

Example Widget

This is an example widget to show how the Right Sidebar looks by default. You can add custom widgets from the widgets screen in the admin. If custom widgets are added then this will be replaced by those widgets.

Copyright © 2023 Clinical Research Society. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.

Offer the visitors your services or goods.

Describe what they will receive and how they will benefit from it.

Do not forget a coaxing call to action, but also a way to decline.
Put the final call to action.

  • Yes I want it!
  • No thank you!